Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Rhodes, Christopher J."'
Autor:
Kariotis S; Department of Neuroscience, University of Sheffield, Sheffield, UK.; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Jammeh E; Department of Neuroscience, University of Sheffield, Sheffield, UK.; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Swietlik EM; Department of Medicine, University of Cambridge, Cambridge, UK.; Royal Papworth Hospital, Cambridge, UK., Pickworth JA; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Rhodes CJ; National Heart and Lung Institute, Imperial College London, London, UK., Otero P; National Heart and Lung Institute, Imperial College London, London, UK., Wharton J; National Heart and Lung Institute, Imperial College London, London, UK., Iremonger J; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Dunning MJ; Department of Neuroscience, University of Sheffield, Sheffield, UK., Pandya D; Department of Medicine, University of Cambridge, Cambridge, UK., Mascarenhas TS; Department of Neuroscience, University of Sheffield, Sheffield, UK., Errington N; Department of Neuroscience, University of Sheffield, Sheffield, UK.; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK., Thompson AAR; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Romanoski CE; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA., Rischard F; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA., Garcia JGN; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA., Yuan JX; Department of Medicine, University of California, San Diego, La Jolla, CA, USA., An TS; Department of Medicine, Indiana University, Indianapolis, IN, USA., Desai AA; Department of Medicine, Indiana University, Indianapolis, IN, USA., Coghlan G; Royal Free Hospital, University College London, London, UK., Lordan J; Newcastle University, Newcastle, UK., Corris PA; Newcastle University, Newcastle, UK., Howard LS; National Heart and Lung Institute, Imperial College London, London, UK., Condliffe R; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Kiely DG; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.; Insigneo institute for In Silico Medicine, Sheffield, UK., Church C; University of Glasgow, Glasgow, UK., Pepke-Zaba J; Royal Papworth Hospital, Cambridge, UK., Toshner M; Department of Medicine, University of Cambridge, Cambridge, UK.; Royal Papworth Hospital, Cambridge, UK., Wort S; National Heart and Lung Institute, Imperial College London, London, UK., Gräf S; Department of Medicine, University of Cambridge, Cambridge, UK., Morrell NW; Department of Medicine, University of Cambridge, Cambridge, UK., Wilkins MR; National Heart and Lung Institute, Imperial College London, London, UK., Lawrie A; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK. a.lawrie@sheffield.ac.uk.; Insigneo institute for In Silico Medicine, Sheffield, UK. a.lawrie@sheffield.ac.uk., Wang D; Department of Neuroscience, University of Sheffield, Sheffield, UK. dennis.wang@sheffield.ac.uk.; Department of Computer Science, University of Sheffield, Sheffield, UK. dennis.wang@sheffield.ac.uk.; Singapore Institute for Clinical Sciences, Singapore, Singapore. dennis.wang@sheffield.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Dec 07; Vol. 12 (1), pp. 7104. Date of Electronic Publication: 2021 Dec 07.
Autor:
Ulrich A; National Heart and Lung Institute, Hammersmith Campus, Imperial College London, London SW7 2BU, UK., Otero-Núñez P; National Heart and Lung Institute, Hammersmith Campus, Imperial College London, London SW7 2BU, UK., Wharton J; National Heart and Lung Institute, Hammersmith Campus, Imperial College London, London SW7 2BU, UK., Swietlik EM; Department of Medicine, University of Cambridge, Cambridge CB2 3AX, UK.; Pulmonary Vascular Disease Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge CB2 0AY, UK., Gräf S; Department of Medicine, University of Cambridge, Cambridge CB2 3AX, UK.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0QQ, UK.; Department of Haematology, University of Cambridge, Cambridge CB2 3AX, UK., Morrell NW; Department of Medicine, University of Cambridge, Cambridge CB2 3AX, UK.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0QQ, UK., Wang D; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2TN, UK.; Sheffield Bioinformatics Core, University of Sheffield, Sheffield S10 2TN, UK., Lawrie A; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield S10 2TN, UK., Wilkins MR; National Heart and Lung Institute, Hammersmith Campus, Imperial College London, London SW7 2BU, UK., Prokopenko I; Department of Clinical and Experimental Medicine, University of Surrey, Guildford GU2 7XH, UK.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2BU, UK., Rhodes CJ; National Heart and Lung Institute, Hammersmith Campus, Imperial College London, London SW7 2BU, UK., Consortium OBOTNBD, Consortium UPCS
Publikováno v:
Genes [Genes (Basel)] 2020 Oct 22; Vol. 11 (11). Date of Electronic Publication: 2020 Oct 22.
Autor:
Rhodes CJ; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Otero-Núñez P; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Wharton J; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Swietlik EM; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Kariotis S; Sheffield Institute for Translational Neuroscience.; Department of Infection, Immunity & Cardiovascular Disease, and., Harbaum L; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Dunning MJ; Sheffield Bioinformatics Core, The University of Sheffield, Sheffield, United Kingdom., Elinoff JM; Critical Care Medicine Department, NIH Clinical Center, Bethesda, Maryland., Errington N; Sheffield Institute for Translational Neuroscience.; Department of Infection, Immunity & Cardiovascular Disease, and., Thompson AAR; Department of Infection, Immunity & Cardiovascular Disease, and., Iremonger J; Department of Infection, Immunity & Cardiovascular Disease, and., Coghlan JG; University College London, London, United Kingdom., Corris PA; Newcastle University, Newcastle upon Tyne, United Kingdom., Howard LS; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Kiely DG; Department of Infection, Immunity & Cardiovascular Disease, and., Church C; University of Glasgow, Glasgow, United Kingdom., Pepke-Zaba J; Royal Papworth Hospital, Cambridge, United Kingdom., Toshner M; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Royal Papworth Hospital, Cambridge, United Kingdom., Wort SJ; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Desai AA; Indiana University, Indianapolis, Indiana., Humbert M; Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.; Service de Pneumologie, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, Le Kremlin-Bicêtre, France.; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France., Nichols WC; Division of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio., Southgate L; Molecular and Clinical Sciences Research Institute, St. George's University of London, London, United Kingdom., Trégouët DA; INSERM UMR_S 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France., Trembath RC; Division of Genetics and Molecular Medicine, King's College London, London, United Kingdom., Prokopenko I; Department of Clinical and Experimental Medicine, University of Surrey, Guildford, United Kingdom; and., Gräf S; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; NIHR BioResource for Translational Research, Cambridge, United Kingdom., Morrell NW; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Wang D; Sheffield Institute for Translational Neuroscience.; Sheffield Bioinformatics Core, The University of Sheffield, Sheffield, United Kingdom., Lawrie A; Department of Infection, Immunity & Cardiovascular Disease, and., Wilkins MR; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Aug 15; Vol. 202 (4), pp. 586-594.
Autor:
Gräf S; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom. sg550@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, United Kingdom. sg550@cam.ac.uk.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0PT, United Kingdom. sg550@cam.ac.uk., Haimel M; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, United Kingdom.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0PT, United Kingdom., Bleda M; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Hadinnapola C; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Southgate L; Molecular and Clinical Sciences Research Institute, St George's, University of London, London, SW17 0RE, United Kingdom.; Division of Genetics & Molecular Medicine, King's College London, London, WC2R 2LS, United Kingdom., Li W; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Hodgson J; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Liu B; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Salmon RM; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Southwood M; Royal Papworth Hospital, Papworth Everard, Cambridge, CB23 3RE, United Kingdom., Machado RD; Institute of Medical and Biomedical Education, St George's University of London, London, SW17 0RE, United Kingdom., Martin JM; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, United Kingdom.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0PT, United Kingdom., Treacy CM; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.; Royal Papworth Hospital, Papworth Everard, Cambridge, CB23 3RE, United Kingdom., Yates K; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, United Kingdom.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0PT, United Kingdom., Daugherty LC; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, United Kingdom.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0PT, United Kingdom., Shamardina O; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, United Kingdom.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0PT, United Kingdom., Whitehorn D; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, United Kingdom.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0PT, United Kingdom., Holden S; Addenbrooke's Hospital, Cambridge, CB2 0QQ, United Kingdom., Aldred M; Cleveland Clinic, Cleveland, Ohio, 44195, United States., Bogaard HJ; VU University Medical Center, Amsterdam, 1007 MB, The Netherlands., Church C; Golden Jubilee National Hospital, Glasgow, G81 4DY, United Kingdom., Coghlan G; Royal Free Hospital, London, NW3 2QG, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, United Kingdom., Corris PA; University of Newcastle, Newcastle, NE1 7RU, United Kingdom., Danesino C; Department of Molecular Medicine, University of Pavia, Pavia, 27100, Italy.; Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy., Eyries M; Département de génétique, hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, and UMR_S 1166-ICAN, INSERM, UPMC Sorbonne Universités, Paris, 75252, France., Gall H; University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL) and of the Excellence Cluster Cardio-Pulmonary System (ECCCPS), Giessen, 35392, Germany., Ghio S; Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy., Ghofrani HA; University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL) and of the Excellence Cluster Cardio-Pulmonary System (ECCCPS), Giessen, 35392, Germany.; Imperial College London, London, SW7 2AZ, United Kingdom., Gibbs JSR; National Heart & Lung Institute, Imperial College London, London, SW3 6LY, United Kingdom., Girerd B; Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay; AP-HP, Service de Pneumologie, Centre de référence de l'hypertension pulmonaire; INSERM UMR_S 999, Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris, 94270, France., Houweling AC; VU University Medical Center, Amsterdam, 1007 MB, The Netherlands., Howard L; Imperial College London, London, SW7 2AZ, United Kingdom., Humbert M; Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay; AP-HP, Service de Pneumologie, Centre de référence de l'hypertension pulmonaire; INSERM UMR_S 999, Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris, 94270, France., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, United Kingdom., Kovacs G; Ludwig Boltzmann Institute for Lung Vascular Research, Graz, 8010, Austria.; Medical University of Graz, Graz, 8036, Austria., MacKenzie Ross RV; Royal United Hospitals Bath NHS Foundation Trust, Bath, BA1 3NG, United Kingdom., Moledina S; Great Ormond Street Hospital, London, WC1N 3JH, United Kingdom., Montani D; Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay; AP-HP, Service de Pneumologie, Centre de référence de l'hypertension pulmonaire; INSERM UMR_S 999, Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris, 94270, France., Newnham M; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Olschewski A; Ludwig Boltzmann Institute for Lung Vascular Research, Graz, 8010, Austria., Olschewski H; Ludwig Boltzmann Institute for Lung Vascular Research, Graz, 8010, Austria.; Medical University of Graz, Graz, 8036, Austria., Peacock AJ; Golden Jubilee National Hospital, Glasgow, G81 4DY, United Kingdom., Pepke-Zaba J; Royal Papworth Hospital, Papworth Everard, Cambridge, CB23 3RE, United Kingdom., Prokopenko I; Imperial College London, London, SW7 2AZ, United Kingdom., Rhodes CJ; Imperial College London, London, SW7 2AZ, United Kingdom., Scelsi L; Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy., Seeger W; University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL) and of the Excellence Cluster Cardio-Pulmonary System (ECCCPS), Giessen, 35392, Germany., Soubrier F; Département de génétique, hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, and UMR_S 1166-ICAN, INSERM, UPMC Sorbonne Universités, Paris, 75252, France., Stein DF; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Suntharalingam J; Royal United Hospitals Bath NHS Foundation Trust, Bath, BA1 3NG, United Kingdom., Swietlik EM; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Toshner MR; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., van Heel DA; Blizard Institute, Queen Mary University of London, London, E1 2AT, United Kingdom., Vonk Noordegraaf A; VU University Medical Center, Amsterdam, 1007 MB, The Netherlands., Waisfisz Q; VU University Medical Center, Amsterdam, 1007 MB, The Netherlands., Wharton J; Imperial College London, London, SW7 2AZ, United Kingdom., Wort SJ; Imperial College London, London, SW7 2AZ, United Kingdom.; Royal Brompton Hospital, London, SW3 6NP, United Kingdom., Ouwehand WH; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, United Kingdom.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0PT, United Kingdom., Soranzo N; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, United Kingdom.; Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, United Kingdom., Lawrie A; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, United Kingdom., Upton PD; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom., Wilkins MR; Imperial College London, London, SW7 2AZ, United Kingdom., Trembath RC; Division of Genetics & Molecular Medicine, King's College London, London, WC2R 2LS, United Kingdom., Morrell NW; Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom. nwm23@cam.ac.uk.; NIHR BioResource-Rare Diseases, Cambridge, CB2 0PT, United Kingdom. nwm23@cam.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2018 Apr 12; Vol. 9 (1), pp. 1416. Date of Electronic Publication: 2018 Apr 12.
Autor:
Rhodes CJ; Department of Medicine, Imperial College London, Hammersmith Campus, London, UK., Wharton J; Department of Medicine, Imperial College London, Hammersmith Campus, London, UK., Ghataorhe P; Department of Medicine, Imperial College London, Hammersmith Campus, London, UK., Watson G; Department of Medicine, Imperial College London, Hammersmith Campus, London, UK., Girerd B; University Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France; AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris, France; Inserm UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, Paris, France., Howard LS; National Heart and Lung Institute, Imperial College London, Hammersmith Campus, London, UK; National Pulmonary Hypertension Service, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Gibbs JSR; National Heart and Lung Institute, Imperial College London, Hammersmith Campus, London, UK; National Pulmonary Hypertension Service, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Simonneau G; University Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France; AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris, France; Inserm UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, Paris, France., Montani D; University Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France; AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris, France; Inserm UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, Paris, France., Sitbon O; University Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France; AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris, France; Inserm UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, Paris, France., Gall H; University of Giessen and Marburg Lung Center, Member of the German Center for Lung Research (DZL), Giessen, Germany., Schermuly RT; University of Giessen and Marburg Lung Center, Member of the German Center for Lung Research (DZL), Giessen, Germany., Ghofrani HA; University of Giessen and Marburg Lung Center, Member of the German Center for Lung Research (DZL), Giessen, Germany., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Humbert M; University Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France; AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris, France; Inserm UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, Paris, France., Wilkins MR; Department of Medicine, Imperial College London, Hammersmith Campus, London, UK. Electronic address: m.wilkins@imperial.ac.uk.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2017 Sep; Vol. 5 (9), pp. 717-726. Date of Electronic Publication: 2017 Jun 15.
Autor:
Tojais NF; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Cao A; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Lai YJ; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Wang L; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Chen PI; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Alcazar MAA; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., de Jesus Perez VA; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Hopper RK; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Rhodes CJ; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Bill MA; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Sakai LY; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.)., Rabinovitch M; From the Department of Pediatrics (N.F.T., A.C., Y.-J.L., L.W., P.I.C., M.A.A.A., R.K.H., C.J.R., M.R.) and Department of Medicine (V.A.d.J.P., M.A.B.), the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA; and Shriners Hospital for Children, Oregon Health & Science University, Portland (L.Y.S.). marlener@stanford.edu.
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2017 Aug; Vol. 37 (8), pp. 1559-1569. Date of Electronic Publication: 2017 Jun 15.
Autor:
Rhodes CJ; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Im H; 2 Cardiovascular Institute.; 4 Department of Genetics, and., Cao A; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Hennigs JK; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Wang L; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Sa S; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Chen PI; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Nickel NP; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Miyagawa K; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Hopper RK; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Tojais NF; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Li CG; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Gu M; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Spiekerkoetter E; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 5 Department of Medicine, Stanford University School of Medicine, Stanford, California., Xian Z; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Chen R; 2 Cardiovascular Institute.; 4 Department of Genetics, and., Zhao M; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Kaschwich M; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Del Rosario PA; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 5 Department of Medicine, Stanford University School of Medicine, Stanford, California., Bernstein D; 2 Cardiovascular Institute.; 3 Department of Pediatrics., Zamanian RT; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 5 Department of Medicine, Stanford University School of Medicine, Stanford, California., Wu JC; 2 Cardiovascular Institute.; 5 Department of Medicine, Stanford University School of Medicine, Stanford, California., Snyder MP; 2 Cardiovascular Institute.; 4 Department of Genetics, and., Rabinovitch M; 1 Vera Moulton Wall Center for Pulmonary Vascular Diseases.; 2 Cardiovascular Institute.; 3 Department of Pediatrics.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2015 Aug 01; Vol. 192 (3), pp. 356-66.
Autor:
Rhodes, Christopher J, Wharton, John, Swietlik, Emilia M, Harbaum, Lars, Girerd, Barbara, Coghlan, J Gerry, Lordan, James, Church, Colin, Pepke-Zaba, Joanna, Toshner, Mark, Wort, Stephen J, Kiely, David G, Condliffe, Robin, Lawrie, Allan, Gräf, Stefan, Montani, David, Boucly, Athénaïs, Sitbon, Olivier, Humbert, Marc, Howard, Luke S, Morrell, Nicholas W, Wilkins, Martin R
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 205:1102-1111
Rationale: NT-proBNP (N-terminal pro-brain natriuretic peptide), a biomarker of cardiac origin, is used to risk stratify patients with pulmonary arterial hypertension (PAH). Its limitations include poor sensitivity to early vascular pathology. Other
Autor:
Ulrich, Anna, Otero-Núñez, Pablo, Wharton, John, Swietlik, Emilia M, Gräf, Stefan, Morrell, Nicholas W, Wang, Dennis, Lawrie, Allan, Wilkins, Martin R, Prokopenko, Inga, Rhodes, Christopher J, Consortium, On Behalf Of The Nihr BioResource-Rare Diseases, Consortium, Uk Pah Cohort Study
Expression quantitative trait loci (eQTL) can provide a link between disease susceptibility variants discovered by genetic association studies and biology. To date, eQTL mapping studies have been primarily conducted in healthy individuals from popula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c115c1fd74769a83421c7fa5ff607ff
Autor:
Kariotis, S, Jammeh, E, Swietlik, EM, Pickworth, JA, Rhodes, CJ, Otero, P, Wharton, J, Iremonger, J, Dunning, MJ, Pandya, D, Mascarenhas, TS, Errington, N, Thompson, AAR, Romanoski, CE, Rischard, F, Garcia, JGN, Yuan, JX-J, An, T-HS, Desai, AA, Coghlan, G, Lordan, J, Corris, PA, Howard, LS, Condliffe, R, Kiely, DG, Church, C, Pepke-Zaba, J, Toshner, M, Wort, S, Graf, S, Morrell, NW, Wilkins, MR, Lawrie, A, Wang, D, Bleda, M, Hadinnapola, C, Haimel, M, Auckland, K, Tilly, T, Martin, JM, Yates, K, Treacy, CM, Day, M, Greenhalgh, A, Shipley, D, Peacock, AJ, Irvine, V, Kennedy, F, Moledina, S, MacDonald, L, Tamvaki, E, Barnes, A, Cookson, V, Chentouf, L, Ali, S, Othman, S, Ranganathan, L, Gibbs, JSR, DaCosta, R, Pinguel, J, Dormand, N, Parker, A, Stokes, D, Ghedia, D, Tan, Y, Ngcozana, T, Wanjiku, I, Polwarth, G, Mackenzie Ross, RV, Suntharalingam, J, Grover, M, Kirby, A, Grove, A, White, K, Seatter, A, Creaser-Myers, A, Walker, S, Roney, S, Elliot, CA, Charalampopoulos, A, Sabroe, I, Hameed, A, Armstrong, I, Hamilton, N, Rothman, AMK, Swift, AJ, Wild, JM, Soubrier, F, Eyries, M, Humbert, M, Montani, D, Girerd, B, Scelsi, L, Ghio, S, Gall, H, Ghofrani, A, Bogaard, HJ, Noordegraaf, AV, Houweling, AC, Veld, AHI, Schotte, G
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
UK National PAH Cohort Study Consortium 2021, ' Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood ', Nature Communications, vol. 12, no. 1, 7104 . https://doi.org/10.1038/s41467-021-27326-0
Nature Communications, 12(1):7104. Nature Publishing Group UK
Nature Communications
UK National PAH Cohort Study Consortium 2021, ' Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood ', Nature Communications, vol. 12, no. 1, 7104 . https://doi.org/10.1038/s41467-021-27326-0
Nature Communications, 12(1):7104. Nature Publishing Group UK
Nature Communications
Idiopathic pulmonary arterial hypertension (IPAH) is a rare but fatal disease diagnosed by right heart catheterisation and the exclusion of other forms of pulmonary arterial hypertension, producing a heterogeneous population with varied treatment res